Ticker Details
Natera, Inc. Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity.
IPO Date:	July 2, 2015
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$40.37B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.60 | 2.60%
Avg Daily Range (30 D):	$6.88 | 2.99%
Avg Daily Range (90 D):	$6.06 | 2.87%

Institutional Daily Volume
Avg Daily Volume:	.76M
Avg Daily Volume (30 D):	1.26M
Avg Daily Volume (90 D):	1.22M

Trade Size
Avg Trade Size (Sh.):	61
Avg Trade Size (Sh.) (30 D):	44
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	7,664
Avg Institutional Trade:	$5.92M
Avg Institutional Trade (30 D):	$22.05M
Avg Institutional Trade (90 D):	$14.42M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$12.69M
Avg Closing Trade (30 D):	$62.95M
Avg Closing Trade (90 D):	$45.24M
Avg Closing Volume:	131.14K

News

Apr 14, 2026 @ 6:30 PM Natera Positioned To Capture Growing $20 Billion M... Source: Vandana Singh

Mar 31, 2026 @ 4:48 PM Natera's Signatera Data Suggests Select Breast Can... Source: Vandana Singh

Feb 28, 2026 @ 9:37 AM 3 Reasons Exelixis Stock Could Deliver Marketâ€... Source: James Halley

Feb 22, 2026 @ 12:30 AM Billionaire Stanley Druckenmiller Is Betting Big o... Source: Lee Samaha

Jan 30, 2026 @ 9:57 AM Esoteric Testing Research Report 2026 - Global $41... Source: Researchandmarkets.Com

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.62	$-.6	$.36
Diluted EPS	$-1.62	$-.6	$.36
Revenue	$2.5B	$696.64M	$665.5M
Gross Profit
Net Income / Loss	$-226.32M	$-85.09M	$47.26M
Operating Income / Loss	$-324.25M	$-93.52M	$-22.79M
Cost of Revenue
Net Cash Flow	$114.16M	$11.79M	$34.7M
PE Ratio